CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-25 | Kompella Uday Director | Option exercise · Option (right to buy) | −10,000 | 116,000 | ||
| 2021-06-15 | Potti Manish Director | Option exercise | +95,880 | $6.30 | $604K | 159,309 |
| 2021-06-15 | Potti Manish Director | Sale | −68,185 | $8.86 | $604K | 91,124 |
| 2021-06-15 | Potti Manish Director | Option exercise · Warrant (Right to Buy) | −95,880 | 0 | ||
| 2021-06-15 | Subramanian Sanjay Chief Financial Officer | Option exercise | +31,000 | $0.34 | $11K | 76,591 |
| 2021-06-15 | Subramanian Sanjay Chief Financial Officer | Sale | −31,000 | $7.00 | $217K | 45,591 |
| 2021-06-15 | Subramanian Sanjay Chief Financial Officer | Option exercise · Option (Right to Buy) | −31,000 | 307,256 | ||
| 2021-06-08 | Musunuri Shankar Chief Executive Officer | Option exercise | +22,800 | $0.33 | $8K | 428,800 |
| 2021-06-08 | Musunuri Shankar Chief Executive Officer | Sale | −22,800 | $10.98 | $250K | 406,000 |
| 2021-06-08 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −22,800 | 1,326,587 | ||
| 2021-06-07 | Castillo Kirsten Director | Sale | −10,000 | $10.00 | $100K | 65,000 |
| 2021-06-07 | Musunuri Shankar Chief Executive Officer | Option exercise | +7,758 | $0.33 | $3K | 413,758 |
| 2021-06-07 | Musunuri Shankar Chief Executive Officer | Sale | −7,758 | $10.94 | $85K | 406,000 |
| 2021-06-07 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −7,758 | 1,349,387 | ||
| 2021-05-28 | Kompella Uday Director | Option exercise | +7,191 | $1.88 | $14K | 557,865 |
| 2021-05-28 | Kompella Uday Director | Sale | −7,191 | $8.82 | $63K | 550,674 |
| 2021-05-28 | Kompella Uday Director | Option exercise · Option (right to buy) | −7,191 | 0 | ||
| 2021-05-25 | Fernandes Prabhavathi Director | Option exercise | +19,500 | $0.28 | $5K | 19,500 |
| 2021-05-25 | Fernandes Prabhavathi Director | Sale | −19,500 | $8.21 | $160K | 0 |
| 2021-05-25 | Fernandes Prabhavathi Director | Option exercise | +14,000 | $1.83 | $26K | 14,000 |
Page 10 of 27 · 525 trades